https://www.sciencedaily.com/releases/2018/10/181004110050.htm
(Quoted from above. To read the full text please go to the above link)
(Quoted from above. To read the full text please go to the above link)
By slightly changing the body's own molecules using a small inhaler,
certain migraine patients can either cut down on medication or do without
it completely. This is shown by a pilot study which has been published in
the scientific journal Cephalalgia.
Patients who suffer from migraine with aura, which is where they
experience either sensory or visual disturbances before the painful
headaches begin, have been examined in the study. Eleven patients
participated in the pilot study, which will now be followed by a large
clinical trial.
One of the authors is MSc in Engineering and PhD Troels Johansen, who
carried out the study as part of his PhD at the Department of Clinical
Medicine at Aarhus University and the Headache Clinic at Aarhus
University Hospital, Denmark.
"The study shows some very significant physiological effects in the body,"
says Troels Johansen, who currently teaches at the Aarhus University
School of Engineering. Together with a team of employees, he has put
the inhaler into production through the company BalancAir.